Baicalein inhibits the expression of stem cell markers CD44highCD24low and octamer-binding transcription factors (OCT)-3 and 4 in triple negative breast cancer cell lines, through the inhibition of interferon-induced protein with tetratricopeptide repeats 2 (IFIT2) [184]. The gene discussed is IFIT2; the disease is triple-negative breast carcinoma.